Yatnam Lab Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -97.44%
- Profit Growth -296.97%
- Ebitda -17203.89%
- Net Worth -95.24%
- Total Assets -5.56%
About Yatnam Lab
Yatnam Lab Limited (YLL) is a Public Limited Indian Non-Government Company incorporated in India on 10 February 2017 (Eight years 13 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chandra Tumuluru, Mohana Chilukuri, and Sudhakar Avuthu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304TG2017PLC115152
- Company No.
115152
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2017
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Yatnam Lab?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Tumuluru  | Director | 10-Feb-2017 | Current |
| Mohana Chilukuri | Director | 10-Feb-2017 | Current |
| Sudhakar Avuthu | Director | 06-Jun-2019 | Current |
Financial Performance of Yatnam Lab.
Yatnam Lab Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.44% decrease. The company also saw a substantial fall in profitability, with a 296.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 95.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yatnam Lab?
In 2023, Yatnam Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hetero Marbles Private LimitedChandra Tumuluru is a mutual person
Dasami Lab Private LimitedMohana Chilukuri is a mutual person
Hetero Biopharma LimitedChandra Tumuluru is a mutual person
- Hetero Labs Limited
Mohana Chilukuri is a mutual person
- Hetero Infrastructure Sez Private Limited
Mohana Chilukuri is a mutual person
- Hetero Wind Power Limited
Sudhakar Avuthu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yatnam Lab?
Unlock and access historical data on people associated with Yatnam Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yatnam Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yatnam Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
